Manulife (Manufacturers Life Insurance)
ICPT

Manulife (Manufacturers Life Insurance)’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-14,985
Closed -$278K – 3054
2023
Q3 		$278K Buy
14,985
+4,581
+44% +$51.8K ﹤0.01% 2408
2023
Q2 		$115K Buy
+10,404
New +$145K ﹤0.01% 2802
2022
Q4 		– Sell
-10,090
Closed -$141K – 3015
2022
Q3 		$141K Sell
10,090
-244
-2% -$3.93K ﹤0.01% 2714
2022
Q2 		$143K Sell
10,334
-796
-7% -$12.7K ﹤0.01% 2808
2022
Q1 		$181K Sell
11,130
-3,376
-23% -$52.9K ﹤0.01% 2812
2021
Q4 		$236 Sell
14,506
-1,499
-9% -$25.3K ﹤0.01% 2788
2021
Q3 		$238K Sell
16,005
-441
-3% -$7.05K ﹤0.01% 2859
2021
Q2 		$328K Buy
16,446
+1,012
+7% +$20.1K ﹤0.01% 2758
2021
Q1 		$356K Sell
15,434
-367
-2% -$10.2K ﹤0.01% 2502
2020
Q4 		$390K Buy
15,801
+473
+3% +$15.7K ﹤0.01% 2352
2020
Q3 		$635K Sell
15,328
-240
-2% -$11K ﹤0.01% 1871
2020
Q2 		$727K Sell
15,568
-574
-4% -$44.3K ﹤0.01% 1772
2020
Q1 		$1.02M Buy
16,142
+858
+6% +$77.1K ﹤0.01% 1511
2019
Q4 		$1.89M Sell
15,284
-296
-2% -$26.5K ﹤0.01% 1412
2019
Q3 		$999K Buy
15,580
+114
+0.7% +$7.66K ﹤0.01% 1645
2019
Q2 		$1.23M Buy
15,466
+1,026
+7% +$91.8K ﹤0.01% 1550
2019
Q1 		$1.61M Buy
14,440
+1,025
+8% +$112K ﹤0.01% 1483
2018
Q4 		$1.35M Sell
13,415
-885
-6% -$91.7K ﹤0.01% 1471
2018
Q3 		$1.81M Sell
14,300
-2,703
-16% -$286K ﹤0.01% 1497
2018
Q2 		$1.43M Buy
17,003
+15,437
+986% +$1.13M ﹤0.01% 1654
2018
Q1 		$96K Buy
1,566
+784
+100% +$47.2K ﹤0.01% 3408
2017
Q4 		$46K Buy
782
+18
+2% +$1.14K ﹤0.01% 3563
2017
Q3 		$44K Buy
764
+20
+3% +$2.15K ﹤0.01% 3507
2017
Q2 		$90K Buy
744
+51
+7% +$5.91K ﹤0.01% 3385
2017
Q1 		$78K Hold
693
– – ﹤0.01% 3263
2016
Q4 		$75K Hold
693
– – ﹤0.01% 3329
2016
Q3 		$114K Buy
693
+45
+7% +$7.09K ﹤0.01% 3153
2016
Q2 		$92K Sell
648
-7
-1% -$1.02K ﹤0.01% 3234
2016
Q1 		$82K Buy
655
+9
+1% +$1.06K ﹤0.01% 3136
2015
Q4 		$96 Hold
646
– – ﹤0.01% 3104
2015
Q3 		$107 Sell
646
-4
-0.6% -$880 ﹤0.01% 3098
2015
Q2 		$157 Buy
650
+52
+9% +$13.8K ﹤0.01% 3070
2015
Q1 		$169 Hold
598
– – ﹤0.01% 2866
2014
Q4 		$93 Buy
598
+39
+7% +$7.2K ﹤0.01% 3086
2014
Q3 		$132 Sell
559
-5
-0.9% -$1.27K ﹤0.01% 2930
2014
Q2 		$133K Sell
564
-5,188
-90% -$1.37M ﹤0.01% 3020
2014
Q1 		$1.9K Sell
5,752
-117
-2% -$39.5K ﹤0.01% 1349
2013
Q4 		$401 Buy
5,869
+403
+7% +$23.3K ﹤0.01% 2215
2013
Q3 		$377 Sell
5,466
-40
-0.7% -$1.98K ﹤0.01% 2175
2013
Q2 		$246K Buy
+5,506
New +$188K ﹤0.01% 2399

Manulife (Manufacturers Life Insurance)'s ICPT Position: Q4 2023 in Review

Manulife (Manufacturers Life Insurance) sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 14,985 shares — an estimated $278K sold.

Manulife (Manufacturers Life Insurance) first reported a position in ICPT in Q2 2013 and held it in 40 quarters. The position peaked at $1.89M in Q4 2019. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

  • Manulife (Manufacturers Life Insurance) reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 14,985 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $278K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2013 and held it in 40 quarters.
  • Manulife (Manufacturers Life Insurance)'s Intercept Pharmaceuticals, Inc. position peaked at $1.89M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2023, filed 13 Feb 2024.